Sharemaestro Newsreel

Earnings call transcript: Senseonics tops revenue forecasts in Q2 2026

Senseonics Holdings reported a strong Q2 2026, with revenue increasing 120% year-over-year to $14.5 million, exceeding analyst forecasts. Despite a slightly wider-than-expected loss per share of 63 cents, the company raised its full-year 2026 revenue guidance to $62 million-$66 million and achieved its strongest …

Artivion (AORT) Q2 Earnings Meet Estimates

Artivion (AORT) reported Q2 earnings of $0.13 per share, meeting the Zacks Consensus Estimate, though this is down from $0.24 a year ago. The company's revenues for the quarter were $125.76 million, surpassing estimates by 4.02%. Artivion's stock has underperformed the S&P 500 this …

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

Analysts’ Top Healthcare Picks: Insulet (PODD), Entrada Therapeutics Inc (TRDA)

This article highlights two healthcare stocks, Insulet (PODD) and Entrada Therapeutics Inc (TRDA), which have received bullish sentiments from analysts. Steven Lichtman of William Blair maintained a Buy rating on Insulet, while Myles Minter, also from William Blair, maintained a Buy rating on Entrada …

Artivion Q2 2026 slides: FDA wins fuel aortic arch expansion

Artivion Inc. reported strong Q2 2026 results, with 9% constant-currency revenue growth driven by stent grafts and On-X mechanical heart valves. The company achieved two major regulatory milestones: FDA PMA approval for the AMDS Hybrid Prosthesis and the completion of the Endospan acquisition following …

Outset Medical (OM) Stock Falls on Q2 2026 Earnings

Outset Medical (OM) reported Q2 2026 revenue of $31.6 million, exceeding analyst expectations, but its stock fell 3.4% after market close due to a widened operating loss and a larger-than-estimated net loss per share. Insider activity shows significant selling, while institutional investors present a …

Earnings call transcript: Outset Medical posts mixed Q2 2026 results, shares edge up

Outset Medical reported mixed Q2 2026 results, with revenue slightly exceeding expectations at $31.6 million but an adjusted loss per share of $0.80, wider than the anticipated $0.75. Shares saw a modest increase of 0.96% in after-hours trading. The company reiterated its full-year 2026 …

Earnings call transcript: STERIS beats Q1 2026 EPS, shares fall on spending plans

STERIS plc reported Q1 2027 earnings that beat analyst estimates but saw its shares fall due to investor concerns over increased capital spending plans, including a new $600 million manufacturing facility in North Carolina, and softer near-term segment trends. Despite the earnings beat and …

(IRTC) IRhythm Technologies Expects 2026 Revenue Range $880M - $890M, vs. FactSet Est of $881.1M

iRhythm Technologies (IRTC) has announced its revenue expectations for 2026, forecasting a range of $880 million to $890 million. This projection is in line with FactSet's estimated revenue of $881.1 million for the same period. The company also reported its Q2 2026 earnings, with …

iRhythm Holdings, Inc. Quarterly Earnings Report

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

iRhythm (NASDAQ:IRTC) Beats Q2 CY2026 Sales Expectations

iRhythm (NASDAQ:IRTC) Beats Q2 CY2026 Sales Expectations Medical technology company iRhythm Technologies (NASDAQ:IRTC) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 20.1% year on year to $224.2 million. The company expects the full year's revenue to be around $885 million, close …

[10-Q] Outset Medical, Inc. Quarterly Earnings Report

UFP Technologies Q2 2026: Revenue $173.96M, EPS $2.68— 10-Q Summary

UFP Technologies reported strong second-quarter 2026 results with revenue of $173.96 million and diluted EPS of $2.68, showing significant year-over-year growth. The company's financial performance was driven by a 15.1% YoY increase in revenue and a 21.3% YoY rise in net income and EPS, …

UFP Technologies (NASDAQ: UFPT) grows Q2 2026 sales and earnings

UFP Technologies reported strong financial results for Q2 2026, with net sales increasing by 15.1% to $174.0 million and diluted EPS reaching $2.68. The growth was primarily driven by its medical sub-markets, leading to an improved gross margin of 29.3%. Despite these gains, the …

Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q2 Revenue $630.9M, vs. FactSet Est of $618.7M

QuidelOrtho Corporation (QDEL) reported its Q2 revenue at $630.9 million, surpassing FactSet's estimate of $618.7 million. This announcement indicates stronger-than-expected financial performance for the company in the second quarter. The article also mentions recent changes in the company's indices and the appointment of a …

QT Imaging Holdings (QTI) director Timm Bryan files Form 3 showing no holdings

QT Imaging Holdings, Inc. director Timm Bryan has filed an initial Form 3, an SEC statement of beneficial ownership. The filing indicates no insider transactions, derivative positions, or reportable holdings in the company's securities for Bryan at the time of disclosure. This Form 3 …

TriSalus Life Sciences, Inc. 2026: Revenue $11.41M, EPS ($0.16) — 10-Q Summary

TriSalus Life Sciences, Inc. (TLSI) reported its 2026 quarterly results, showing revenue of $11.41M, which was nearly flat year-over-year, and a net loss of ($9.19M), resulting in a diluted loss per share of ($0.16). The company highlighted stable revenue, improved gross margin, continued commercial …

Sight Sciences, Inc. Stock 12‑Month Price Target Raised to $8.6, Implies 55% Upside

The average 12-month price target for Sight Sciences, Inc. (SGHT) stock has been raised from $8.4 to $8.6 by 5 analysts, with a range of $6 to $12 per share. This new target suggests a potential upside of approximately 55% based on the August …

Segall Bryant & Hamill LLC Acquires New Holdings in Tactile Systems Technology, Inc. $TCMD

Segall Bryant & Hamill LLC has acquired 49,382 shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) worth approximately $1.29 million, indicating growing institutional interest in the company. Other institutional investors have also increased their stakes in TCMD, with 83.43% of the stock now owned by …

Janus Henderson Group PLC Purchases 127,942 Shares of Tactile Systems Technology, Inc. $TCMD

Janus Henderson Group PLC increased its stake in Tactile Systems Technology, Inc. (TCMD) by 67.4% in the first quarter, acquiring an additional 127,942 shares to bring its total holdings to 317,695 shares valued at $8.3 million. Institutional investors now own 83.43% of the company, …

Steris Posts Solid Q1 Results Amid Restructuring Plans

STERIS (STE) reported strong fiscal 2027 first-quarter results with 7% revenue growth and increased EPS, driven by its Healthcare segment and solid gains in Life Sciences and Applied Sterilization Technologies. The company announced a restructuring plan involving facility consolidations, incurring estimated charges of $55-70 …

Needham raises Establishment Labs stock price target on strong results

Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line

Haemonetics Corporation 2027 Q1 - Results - Earnings Call Presentation (NYSE:HAE) 2026-08-06

Sanuwave Announces Q2 FY2026 Financial Results

Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. Q2 2026 gross margin was 76.2%, versus 78.1% in Q2 2025. GAAP Operating (Loss) Income was $(0.3) million for Q2 2026 versus $1.4 million in Q2 2025. EDEN PRAIRIE, Minn., …

Beyond Air regains Nasdaq bid-price compliance after 1-for-20 reverse split; discretionary monitor imposed

Beyond Air (XAIR) has regained compliance with Nasdaq's $1.00 bid-price rule following a 1-for-20 reverse stock split effected on July 13, 2026. The company maintained a closing bid price of $1.00 or greater for 17 consecutive trading days. Nasdaq has imposed a one-year Discretionary …

Form 8K Beyond Air Inc For: 6 August By Investing.com

This article from Investing.com reports on Beyond Air Inc.'s Form 8K filing for August 6th. The content primarily consists of market data, including various indices, commodities, currencies, and stock performance, but offers no further details on the specific contents of Beyond Air's filing. It …

Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows

Hyperfine (Nasdaq: HYPR) reported a 44.8% increase in Q2 2026 revenue, reaching $3.904 million, with commercial Swoop system sales rising and gross margin expanding, which helped narrow the operating loss. Despite operational improvements, the net loss remained nearly flat at $9.298 million due to …

Artivion (NYSE:AORT) Delivers Strong Q2 CY2026 Numbers

Artivion (NYSE:AORT) reported strong Q2 CY2026 results, with revenue of $125.8 million, beating analyst estimates by 4.4%, and non-GAAP EPS of $0.13, exceeding estimates by 34.5%. The medical device company reconfirmed its full-year revenue guidance and provided optimistic EBITDA guidance. Despite a decrease in …

electroCore Announces Second Quarter 2026 Financial Results

electroCore announced strong second-quarter 2026 financial results, with net sales increasing by 28% to $9.5 million, driven by growth in U.S. prescription sales and Truvaga sales. The company reduced its net loss by 17% and improved Adjusted EBITDA by 26% year-over-year. electroCore also raised …

[10-Q] electroCore, Inc. Quarterly Earnings Report

electroCore, Inc. (ECOR) filed its quarterly earnings report (Form 10-Q) for the period ending June 30, 2026, revealing funding shortfalls and raising substantial doubt about its ability to continue as a going concern. The company reported a net loss of $8.3 million for the …

Artivion: Q2 Earnings Snapshot

Artivion, Inc. (AORT) reported a second-quarter loss of $13.5 million, or 28 cents per share, which contrasts with a profit in the same period last year. Adjusted earnings for the biological medical device maker were 13 cents per share, with revenue reaching $130.8 million. …

Earnings Flash (AORT) Artivion, Inc. Reports Q2 Revenue $125.8M, vs. FactSet Est of $120.0M

Artivion, Inc. (AORT) has reported its Q2 revenue of $125.8 million, surpassing FactSet's estimate of $120.0 million. This earnings flash indicates a positive financial performance for the medical device company. The news was published on August 6, 2026, at 05:07 pm EDT.

Outset Medical Inc. (OM) Misses Q2 EPS by 5c

Outset Medical Inc. (OM) reported its Q2 earnings, missing analyst estimates for EPS by $0.05, with an EPS of ($0.80) against an anticipated ($0.75). Despite the EPS miss, the company slightly exceeded revenue expectations, bringing in $31.6 million compared to the consensus estimate of …

Globus Medical lifts 2026 non-GAAP EPS guidance to $4.95-$5.05